{"id":"doi:10.1056/nejmoa2604169","kind":"article","title":"Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity","authors":["Ania M. Jastreboff","Lee M. Kaplan","Melanie Jane Davies","John P.H. Wilding","Nadia N. Ahmad","Megan H. Murray","Yu Du","Nune Makarova","Kathryn A. Giblin","Nanette Cathrin Schloot","Yan Wang"],"author_count":11,"year":2026,"published":"2026-09-29","venue":"New England Journal of Medicine","cited_by":2,"doi":"10.1056/nejmoa2604169","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2604169","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2604169","updated":null,"pmid":"42814954","pmcid":null,"openalex_id":"W7214802080","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}